Awaiting FDA action on YUTREPIA™ NDA with a PDUFA goal date of May 24, 2025 District Court dismissed cross claim filed by United Therapeutics challenging PH-ILD amendment Fully enrolled Cohort A of ...

A pharmaceutical company that specializes in the production of medication kits used for the treatment of diabetes, ...

The FDA has approved HemiClor (12.5 mg chlorthalidone) tablets for the treatment of hypertension in adults, to lower blood pressure.